Dose-response relationship in experimental and clinical oncology

Freireich, 1983, Dose response relationship in clinical oncology, 1 Gehan, 1983, Dose-response relationship in clinical oncology, 43 Goldin, 1983, Dosing and sequencing for antineoplastic synergism in combination chemotherapy, 2 Hilgard, 1983, Human dose and schedule finding based on animal experiments, 14 Klein, 1983, Investigations on pharmacokinetics and cytocydal activity of some antitumor drugs administered by push injection or continuous infusion, 40 McVie, 1983, The role of pharmacokinetics in dose and schedule finding (combination) chemotherapy, 23 Morton, 1983, Regional intraarterial chemotherapy combined with radiation or hyperthermia for management of primary or metastatic neoplasms, 54 Nagel, 1983, Low versus high dose hormones in the treatment of malignant tumors, 49 Osieka, 1983, Primary and acquired resistance to antineoplastic chemotherapy, 17 Schabel, 1983, Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology, 8 Spitzer, 1983, High-dose combination chemotherapy with autologous bone marrow (ABMT), 57 Varini, 1983, Antitumor drug distribution in plasma, urine and tissue of patients with lung carcinoma, 36 Voelcker, 1983, Correlation of human pharmacokinetics of ‘activated’ cyclophosphamide and therapeutic effects (problems of simulation in nude mice), 28